Dimor Elbers

Board member

Dimor Elbers is Associate Director at Lonza, one of the world’s leading suppliers to the Pharma&Biotech and Specialty Ingredient markets. Dimor Elbers is Associate Director at Lonza and represents Lonza’s Pharma&Biotech contract manufacturing in the Benelux, Israel & Russia for Biologics.

Dimor works for the Clinical Development business unit since its establishment in 2011. The Clinical Development business unit focuses on getting new innovative therapies to the clinic,

Lonza’s focus is on improvement of production yield, manufacturability, safety, Regulatory acceptance, scalability and Cost of Goods of customer’s biopharmaceutical API’s in order to make innovative products economically viable and successful. Also in-house development & production at the customer side is offered under several licensing options.

Lonza is one of the world’s leading suppliers to the Pharma&Biotech and Specialty Ingredient markets with a huge network of global GMP manufacturing facilities. Lonza is committed to the life science industry through its world-class contract manufacturing and complete range of development services for fine chemicals, advanced intermediates, active pharmaceutical ingredients (APIs), biologics, and functional ingredients. From early development through commercial manufacturing and mature market supply, Lonza’s lifecycle management experience and track record in the field of contract manufacturing is unparalleled.
2001 – 2008 Worked at Sigma-Aldrich for Research Biotech in the Benelux. Specialist for Molecular Biology, including the siRNA & shRNA libraries for RNA interference. Also lead the addition of Corning Life Science products and the integration of Isotec for Stable isotopes in Sigma-Aldrich Benelux.

1998-2001 Expansion of 10P’s in The Netherlands for Research & Development reagents & kits from broad variety of brands. 10P’s was a specialized distributor in life science research products and represented Invitek, Serva, Novex, Embi Tec, Q-Biogene, etc
Dimor Elbers went to the University Utrecht in The Netherlands and graduated in Molecular Genetics in 1998. Dissertation titled “Development of unusually large offspring following nuclear transfer/ cloning. The large offspring phenomenon”. Internship at Pharming B.V. for analysis of Transgenesis in transgenic cattle.